全文获取类型
收费全文 | 30265篇 |
免费 | 2147篇 |
国内免费 | 74篇 |
专业分类
耳鼻咽喉 | 246篇 |
儿科学 | 718篇 |
妇产科学 | 525篇 |
基础医学 | 3974篇 |
口腔科学 | 708篇 |
临床医学 | 2676篇 |
内科学 | 5609篇 |
皮肤病学 | 488篇 |
神经病学 | 3091篇 |
特种医学 | 1267篇 |
外国民族医学 | 55篇 |
外科学 | 3941篇 |
综合类 | 372篇 |
一般理论 | 10篇 |
预防医学 | 4044篇 |
眼科学 | 792篇 |
药学 | 1931篇 |
中国医学 | 32篇 |
肿瘤学 | 2007篇 |
出版年
2023年 | 116篇 |
2022年 | 243篇 |
2021年 | 409篇 |
2020年 | 319篇 |
2019年 | 405篇 |
2018年 | 524篇 |
2017年 | 456篇 |
2016年 | 494篇 |
2015年 | 627篇 |
2014年 | 803篇 |
2013年 | 1226篇 |
2012年 | 1601篇 |
2011年 | 1659篇 |
2010年 | 1000篇 |
2009年 | 959篇 |
2008年 | 1597篇 |
2007年 | 1705篇 |
2006年 | 1649篇 |
2005年 | 1649篇 |
2004年 | 1568篇 |
2003年 | 1456篇 |
2002年 | 1480篇 |
2001年 | 482篇 |
2000年 | 392篇 |
1999年 | 485篇 |
1998年 | 466篇 |
1997年 | 495篇 |
1996年 | 464篇 |
1995年 | 373篇 |
1994年 | 266篇 |
1993年 | 330篇 |
1992年 | 237篇 |
1991年 | 211篇 |
1990年 | 196篇 |
1989年 | 222篇 |
1988年 | 220篇 |
1987年 | 214篇 |
1986年 | 199篇 |
1985年 | 195篇 |
1984年 | 232篇 |
1983年 | 206篇 |
1982年 | 243篇 |
1981年 | 224篇 |
1980年 | 202篇 |
1979年 | 175篇 |
1978年 | 160篇 |
1977年 | 115篇 |
1976年 | 159篇 |
1975年 | 133篇 |
1974年 | 156篇 |
排序方式: 共有10000条查询结果,搜索用时 296 毫秒
101.
102.
103.
Clemens Aigner Peter Jaksch Samy Mazhar Kriztina Czebe Gabriel Marta Sharokh Taghavi Georg Lang Walter Klepetko 《European journal of cardio-thoracic surgery》2004,25(2):184-187
OBJECTIVES: The use of OKT3 for treatment of advanced high-grade acute rejection episodes eventually can result in cytokine release and consecutive pulmonary edema. Temporary extracorporeal membrane oxygenation (ECMO) bridging can be used to overcome this crucial period before the beneficial effects of OKT3 can be observed. METHODS: We summarize our experience with three patients, who underwent lung transplantation and presented with severe acute rejection episodes. OKT3 had to be initiated due to insufficient response to standard rejection therapy with corticosteroids. Upon initiation of OKT3 treatment, a massive life-threatening deterioration of lung function in spite of heavily invasive respirator treatment was seen and temporary ECMO support was imperative to support graft function. Results of this treatment were retrospectively reviewed. RESULTS: In all cases femoro-femoral veno-arterial ECMO was used for support of the impaired graft and after a period of 4-5 days led to a massive improvement of graft function. In the further course two patients could be discharged from hospital and are still alive 30 and 36 months, respectively, after the described incident. One patient died 4 months later due to liver failure. CONCLUSIONS: We conclude that the use of ECMO support in patients experiencing significant side effects from OKT3 therapy is a useful and effective therapeutic tool to overcome the initial critical period until the lung has sufficiently recovered. 相似文献
104.
105.
ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. 总被引:3,自引:0,他引:3
Didier Lardinois Paul De Leyn Paul Van Schil Ramon Rami Porta David Waller Bernward Passlick Marcin Zielinski Toni Lerut Walter Weder 《European journal of cardio-thoracic surgery》2006,30(5):787-792
The European Society of Thoracic Surgeons (ESTS) organized a workshop dealing with lymph node staging in non-small cell lung cancer. The objective of this workshop was to develop guidelines for definitions and the surgical procedures of intraoperative lymph node staging, and the pathologic evaluation of resected lymph nodes in patients with non-small cell lung cancer (NSCLC). Relevant peer-reviewed publications on the subjects, the experience of the participants, and the opinion of the ESTS members contributing on line, were used to reach a consensus. Systematic nodal dissection is recommended in all cases to ensure complete resection. Lobe-specific systematic nodal dissection is acceptable for peripheral squamous T1 tumors, if hilar and interlobar nodes are negative on frozen section studies; it implies removal of, at least, three hilar and interlobar nodes and three mediastinal nodes from three stations in which the subcarinal is always included. Selected lymph node biopsies and sampling are justified to prove nodal involvement when resection is not possible. Pathologic evaluation includes all lymph nodes resected separately and those remaining in the lung specimen. Sections are done at the site of gross abnormalities. If macroscopic inspection does not detect any abnormal site, 2-mm slices of the nodes in the longitudinal plane are recommended. Routine search for micrometastases or isolated tumor cells in hematoxylin-eosin negative nodes would be desirable. Randomized controlled trials to evaluate adjuvant therapies for patients with these conditions are recommended. The adherence to these guidelines will standardize the intraoperative lymph node staging and pathologic evaluation, and improve pathologic staging, which will help decide on the best adjuvant therapy. 相似文献
106.
107.
108.
109.
110.
Demetrius M Maraganore Matthew J Farrer Timothy G Lesnick Mariza de Andrade James H Bower Dena Hernandez John A Hardy Walter A Rocca 《Movement disorders》2003,18(11):1233-1239
We conducted a case-control study of the alpha-synuclein-interacting protein gene (SNCAIP, also known as synphilin-1) and Parkinson's disease (PD). A total of 319 PD cases and 195 controls were genotyped for four SNCAIP variants, including a microsatellite repeat in intron 4 and three restriction fragment length polymorphisms (RFLP) proximal to the 5' terminal of exons 1, 4, and 6. None of the variants were found associated with PD overall. Global score statistics were not significant for four, three, and two loci haplotypes. All four loci were in linkage disequilibrium for cases, controls, or both groups combined (P < 0.0001). Recursive partitioning showed no interactions between variants of the SNCAIP gene and variants of the alpha-synuclein gene (SNCA) or the parkin (PARK2) gene. 相似文献